ARS-1620
Pou rechèch syantifik sèlman, pa pou pasyan yo.
Pwodwi detay
Tags pwodwi
| Gwosè pake | Disponibilite | Pri (USD) |
| 100 mg | Nan Stock | 800 |
| 500 mg | Nan Stock | 1500 |
| 1g | Nan Stock | 2000 |
| Plis gwosè | Jwenn Quotes | Jwenn Quotes |
Non Chimik:
(S)-1-(4-(6-chloro-8-fluoro-7-(2-fluoro-6-hydroxyphenyl)quinazolin-4-yl)piperazin-1-yl)prop-2-en-1-one
Kòd SMILES:
C=CC(=O)N1CCN(CC1)C2=C3C=C(C(=C4C(=O)C=CC=C4F)C(=C3NC=N2)F)Cl
Kòd InChi:
InChI=1S/C21H17ClF2N4O2/c1-2-16(30)27-6-8-28(9-7-27)21-12-10-13(22)17(19(24)20(12)25- 11-26-21)18-14(23)4-3-5-15(18)29/h2-5,10-11,29H,1,6-9H2
InChi kle:
QIQWMIZVWVSRAS-UHFFFAOYSA-N
Mot:
ARS-1620, KRAS G12C, NSCLC, ARS1620, ARS 1620, KRASG12C, 1698055-85-4
Solibilite:Soluble nan DMSO
Depo:0 - 4 ° C pou kout tèm (jou a semèn), oswa -20 ° C pou tèm long (mwa)
Deskripsyon:
ARS-1620 se yon prodrog ki fèt nan ARS-853, ki se yon inibitè S-IIP G12C ki pisan ak selektif. ARS-1620 espere yon estrateji ki ka geri pou kansè mutan p.G12C KRAS.
Sib: KRAS (K-Ras G12C)
